Journal of Crohns & Colitis
Journal Abbreviation: J CROHNS COLITIS
ISSN: 1873-9946
Publisher: Elsevier
Publications (73)
The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis (2018)
Schmitt H, Billmeier U, Ulmschneider J, Admyre C, Knittel T, Zargari A, Neurath M, Atreya R
Conference contribution
Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02) (2017)
Siegel CA, Lichtenstein G, Siegmund B, Lewis JD, Wolf D, Louis E, Sebastian S, et al.
Conference contribution
Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease (2017)
Atreya R, Kuehbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al.
Conference contribution
IL-10 induction properties of the TLR-9 agonist cobitolimod - a candidate for treatment of active ulcerative colitis in late stage of clinical development (2017)
Admyre C, Zargari A, Atreya R, Knittel T
Conference contribution
Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions (2017)
Suzuki K, Yokoyama J, Kawauchi Y, Honda Y, Sato H, Aoyagi Y, Terai S, et al.
Journal article
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? (2016)
Genua M, Becker C, Vetrano S
Journal article
High-resolution quantitative computed tomography demonstrates structural defects in cortical and trabecular bone in IBD patients. (2016)
Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Faustini F, Simon D, Figueiredo CP, et al.
Journal article
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis (2016)
Atreya R, Bloom S, Scaldaferri F, Gerardi V, Admyre C, Karlsson A, Knittel T, et al.
Journal article
Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases (2016)
Atreya I, Diall A, Dvorsky R, Atreya R, Henninger C, Gruen M, Hofmann U, et al.
Journal article
Primary Manifestation of Inflammatory Bowel Disease Following Subcutaneous Autovaccination (2015)
Raithel M, Weidenhiller M, Hahn M, Hagel A, Bechthold C, Neurath M, Rieker RJ, Stein J
Journal article